The weight-loss drugs are coming for these companies — but here's why Coke, others, may be spared, says JPMorganMarket Watch • 10/24/23
Leading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote “FOR” Danaher Corporation's Proposed Acquisition of AbcamBusiness Wire • 10/23/23
7 Stocks to Buy Before They Become the Next Trillion-Dollar Companies: October EditionInvestorPlace • 10/19/23
Leading Proxy Advisor, ISS, Recommends Shareholders Vote “FOR” Danaher Corporation's Proposed Acquisition of AbcamBusiness Wire • 10/17/23
Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the CompanyGlobeNewsWire • 10/16/23
Exlusive: Why Abcam founder believes Danaher's acquisition offer falls shortProactive Investors • 10/16/23
Independent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to DanaherBusiness Wire • 10/12/23
ABCAM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abcam plc - ABCMBusiness Wire • 10/10/23
Abcam Files and Mails Scheme Circular Seeking Approval of Acquisition of Abcam by Danaher for $24.00 per ShareBusiness Wire • 10/05/23
Veralto Set to Join S&P 500; Vestis to Join S&P MidCap 400; Others to Join S&P SmallCap 600PRNewsWire • 09/28/23
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Danaher Corporation with Losses of $100,000 to Contact the FirmAccesswire • 09/15/23